Articles by Suzanne Hodsden
-
Valeant Acquires Nicox Diagnostics Subsidiary In $20M Deal
11/21/2014
Nicox announced today the sale of its U.S. diagnostic subsidiary to Valeant for $10 million cash up front and an additional $10 million to be delivered when sales goals for transferred products are met. The deal allows Valeant to strengthen its footing in the ophthalmology field while allowing Nicox to focus its attentions on therapeutics.
-
New Australian Design Uses Sound Waves To Administer Aerosol Vaccine
11/20/2014
Scientists from Murdoch Children’s Research Institute and Monash University in Australia have designed a new method for administering inhalable vaccines by using sound waves to aerosolize vaccines, The Herald Sun reports.
-
New Drug Could Boost Vaccine Efficacy In Elderly Patients
11/17/2014
Scientists at Oxford University have discovered a new compound which could potentially boost the immune systems of elderly patients and make their systems more receptive to vaccines, MedicalXpress reports.
- Dutch Scientists Launch Bacteria-Killing Biologic 11/14/2014
-
Industry Responds To San Francisco’s "Take Back Program"
11/6/2014
Lawmakers in San Francisco are trying to curb the misuse and environmental threat of unused pharmaceuticals by designing a take-back program which they hope can be funded and designed by drug makers themselves. Representatives from the industry have responded to the bill, calling into question whether it is feasible or constitutional.
-
Indian Government To Reduce Import Of Chinese APIs
11/6/2014
There is a growing concern in India that the domestic pharma industry has developed an over dependence on China for the manufacture of active pharmaceutical ingredients (APIs). LiveMint reports that the Indian government intends to make locally manufactured APIs more attractive and available for Indian drug makers.
-
New Biotech Launches With Focus On Novel Conjugate Vaccines
11/5/2014
Thanks to a $4 million dollar investment by the Bill & Melinda Gates Foundation (BMGF), Affinivax announced its launch. The brand new biotechnology company will develop novel conjugate vaccines based on its newly purchased license Multiple Antigen Presenting System (MAPS).
-
Will Generic Drug Manufacturing Move Back to the U.S.?
11/4/2014
CPhl and InformX conducted a comprehensive report which surveyed both international and domestic drug companies about the future of the U.S. pharma market.
-
CDSCO Steps Up Quality Control In India
11/4/2014
The Central Drugs Standard Control Organization (CDSCO) announced plans to survey a broad selection of drug samples available on the Indian market to counter recent complaints of substandard manufacturing, reports The Business Standard.
-
Fujifilm Enters Vaccine Contract Manufacturing Business
10/30/2014
Fujifilm announced that it has invested in a large stake of the Texas-based contract manufacturing organization (CMO) Kalon in order to expand its pharmaceutical business into the biopharma sector.